Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2024 Earnings Call Transcript August 13, 2024
Fennec Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $0.06.
Operator: Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Second Quarter 2024 Earnings and Corporate Update Conference Call. [Operator Instructions] As a reminder, today’s conference call is being recorded. Now I’d like to turn the conference over to Fennec’s Chief...
